Industries > Pharma > Global Norovirus Vaccines in Pipeline Forecast 2020-2030

Global Norovirus Vaccines in Pipeline Forecast 2020-2030

Takeda, Vaxart, Cocrystal Pharma, PanTheryx, Calici Therapeutics

PUBLISHED: 19 December 2019
PAGES: 98
PRODUCT CODE: PHA0643
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0643 Categories: , Tags: ,

The global norovirus vaccines market is estimated to grow at a CAGR of 7.6% during the forecast period. In 2022, North America is expected to hold a market share of 61% of the global norovirus vaccines market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

The report provides clear detailed insight into the global norovirus vaccines in pipeline forecast. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Norovirus Vaccines in Pipeline forecast from 2020-2030

• Global Norovirus Vaccines in Pipeline forecast from 2020-2030 by Regional and National Market:
• North America: US, Canada
• EU5: Germany, France, UK, Italy, Spain
• APAC: Japan, China, India, Australia, ASEAN, Rest of APAC
• Central and South America: Brazil, Argentina, Rest of Central and South America
• Middle East and Africa: GCC, South Africa, North Africa, Rest of MEA

Global Norovirus Vaccines in Pipeline Forecast 2020-2030

• Profiles of the selected leading companies:
• Calici Therapeutics
• Cocrystal Pharma
• PanTheryx
• Takeda
• Vaxart

• List and discussion of candidate vaccines

• Key Questions Answered by this Report:
• What is the current size of the overall global norovirus vaccines market? How much will this market be worth from 2020 to 2030?
• What are the main drivers and restraints that will shape the overall norovirus vaccine market over the next ten years?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world vaccines? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2030?
• How will market shares of the leading national markets change by 2030, and which geographical region will lead the market in 2030?
• Who are the leading companies and what are their activities, results, developments and prospects?
• What are some of the most prominent norovirus vaccines currently in development?
• What are the main trends that will affect the world norovirus vaccines market between 2020 and 2030?
• What are the main strengths, weaknesses, opportunities and threats for the market?
• What are the demographic influences that will shape that industry over the next ten years?
• How will the global norovirus vaccines market evolve over the forecasted period, 2020 to 2030?

Buy our report today Global Norovirus Vaccines in Pipeline Forecast 2020-2030: Takeda, Vaxart, Cocrystal Pharma, PanTheryx, Calici Therapeutics.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Norovirus Vaccines in Pipeline Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Norovirus Vaccines in Pipeline Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

READ

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

READ

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Categories